IL49355A - Pharmaceutical composition comprising sodium l-ascorbate 2-sulfate - Google Patents
Pharmaceutical composition comprising sodium l-ascorbate 2-sulfateInfo
- Publication number
- IL49355A IL49355A IL49355A IL4935576A IL49355A IL 49355 A IL49355 A IL 49355A IL 49355 A IL49355 A IL 49355A IL 4935576 A IL4935576 A IL 4935576A IL 49355 A IL49355 A IL 49355A
- Authority
- IL
- Israel
- Prior art keywords
- ascorbate
- sulfate
- sodium
- pharmaceutical composition
- pharmaceutical
- Prior art date
Links
- AMQDHYXCJCIBQJ-YCWPWOODSA-L disodium;[(2r)-2-[(1s)-1,2-dihydroxyethyl]-3-oxido-5-oxo-2h-furan-4-yl] sulfate Chemical compound [Na+].[Na+].OC[C@H](O)[C@H]1OC(=O)C(OS([O-])(=O)=O)=C1[O-] AMQDHYXCJCIBQJ-YCWPWOODSA-L 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/62—Three oxygen atoms, e.g. ascorbic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4185575 | 1975-04-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL49355A0 IL49355A0 (en) | 1976-06-30 |
IL49355A true IL49355A (en) | 1979-09-30 |
Family
ID=12619855
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL49355A IL49355A (en) | 1975-04-08 | 1976-04-05 | Pharmaceutical composition comprising sodium l-ascorbate 2-sulfate |
Country Status (6)
Country | Link |
---|---|
DE (1) | DE2615372A1 (enrdf_load_stackoverflow) |
FR (1) | FR2306689A1 (enrdf_load_stackoverflow) |
GB (1) | GB1489734A (enrdf_load_stackoverflow) |
IL (1) | IL49355A (enrdf_load_stackoverflow) |
NL (1) | NL7603698A (enrdf_load_stackoverflow) |
ZA (1) | ZA762124B (enrdf_load_stackoverflow) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4169202A (en) * | 1978-06-05 | 1979-09-25 | American Home Products Corporation | Process for preparing 4,5-dihydro-4-oxofuran-2-carboxylic acid derivatives |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1452844A (en) * | 1973-11-07 | 1976-10-20 | Kumiai Chemical Industry Co | Process for producing salts of l-asorbic acid-2-sulphate |
-
1976
- 1976-04-02 GB GB13416/76A patent/GB1489734A/en not_active Expired
- 1976-04-05 IL IL49355A patent/IL49355A/xx unknown
- 1976-04-08 ZA ZA762124A patent/ZA762124B/xx unknown
- 1976-04-08 DE DE19762615372 patent/DE2615372A1/de active Pending
- 1976-04-08 FR FR7610294A patent/FR2306689A1/fr active Granted
- 1976-04-08 NL NL7603698A patent/NL7603698A/xx not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DE2615372A1 (de) | 1976-10-21 |
IL49355A0 (en) | 1976-06-30 |
GB1489734A (en) | 1977-10-26 |
ZA762124B (en) | 1977-04-27 |
NL7603698A (nl) | 1976-10-12 |
FR2306689A1 (fr) | 1976-11-05 |
FR2306689B1 (enrdf_load_stackoverflow) | 1978-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA7671B (en) | Pharmaceutical composition | |
JPS5272829A (en) | Pharmaceutical composition | |
HK34380A (en) | Pharmaceutical compositions | |
ZA74385B (en) | Pharmaceutical compositions | |
IL48508A (en) | Pharmaceutical compositions comprising piperidylindole derivatives | |
ZA762748B (en) | Pharmaceutical compositions | |
IL49280A (en) | Pharmaceutical compositions containing substituted o-hydroxy-benzophenone derivatives | |
AU1306576A (en) | Pharmaceutical formulation | |
IL48063A0 (en) | New benzofuran derivatives,their manufacture and pharmaceutical compositions containing them | |
HK17281A (en) | Pharmaceutical compositions | |
NZ179502A (en) | Ii-desoxy-omega-tetra norprostaglanding internediates pharmaceutical composition | |
ZA767215B (en) | Pharmaceutical compositions | |
ZA761880B (en) | New pharmaceutical compositions | |
IL49355A (en) | Pharmaceutical composition comprising sodium l-ascorbate 2-sulfate | |
GB1552416A (en) | Pharmaceutical compositions | |
IE42772L (en) | Pharmaceutical compositions | |
IL48098A0 (en) | Pharmaceutical compositions containing diphenylethanol derivatives | |
ZA755802B (en) | Pharmaceutical compositions | |
KE2903A (en) | Pharmaceutical compositions | |
IE43955L (en) | Pharmaceutical composition | |
ZA763806B (en) | Pharmaceutical compositions | |
IL51043A0 (en) | Novel pharmaceutical compositions comprising ergot-type compounds | |
ZA755515B (en) | Pharmaceutical formulations | |
ZA752585B (en) | Pharmaceutical composition | |
AU1172076A (en) | Pharmaceutical compositions |